Norbert Metzdorf

Effect of a single exacerbation on decline in lung function in COPD

David Halpin, Marc Decramer, Bartolomé R. Celli et al. · Respiratory Medicine · 2017 · 110 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13

Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial

Lucas Goossens, Inge Leimer, Norbert Metzdorf et al. · BMC Pulmonary Medicine · 2014 · 68 citations · Full text

Medicine, Chronic Disease Control, Clinical Classification Systems +16

Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial

Donald P. Tashkin, Inge Leimer, Norbert Metzdorf et al. · Respiratory Research · 2015 · 49 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study

Peter M.A. Calverley, Kay Tetzlaff, Daniel Dusser et al. · International Journal of COPD · 2017 · 45 citations · Full text

Medicine, Internal Medicine, Epidemiology +15

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR<sup>®</sup> trial

Robert A. Wise, Peter M.A. Calverley, Kerstine Carter et al. · International Journal of COPD · 2018 · 33 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17